LMS Medical Sees Fiscal 2008 Revenue Jump 72% Over F07 - Q4/F08 Revenue Hits New Record

Thursday, May 15, 2008 General News J E 4
MONTREAL, May 14 /PRNewswire-FirstCall/ - LMS Medical Systems (TSX: LMZ,)a healthcare technology company and developer of the CALM(R) patient safetysoftware system for obstetrics, today reported preliminary results for Fiscal2008 (March 31), which saw a substantial rise in revenues over the previousfiscal year. All amounts are in Canadian dollars and are unaudited.

Revenue continues to grow substantially year over year. For F08, revenuetotaled $4.92 million compared to $2.86 million in F07 and $1.58 million inF06. Fourth quarter revenue totaled $2.28 million, a 59% increase compared to$1.43 million in the fourth quarter of F07. Fourth quarter revenue in F06totaled $.3 million.

Also, as a significant percentage of the company's revenues come from theUnited States, the strength of the Canadian dollar impacted results. At aconstant rate of exchange as of the beginning of the fiscal year, revenuewould have increased by an additional 12%.

Complete audited results for the fiscal year ended March 31, 2008 andManagement's Discussion and Analysis will be released on or about June 13,2008.

About LMS: LMS is a leader in the application of advanced mathematicalmodeling and neural networks for medical use. The LMS CALM Suite providesphysicians, nursing staff, risk managers and hospital administrators withclinical information systems and risk management tools designed to improveoutcomes and patient care for mothers and their infants during childbirth.

Except for historical information contained herein, the matters discussedin this news release are forward-looking statements. Because theseforward-looking statements involve risks and uncertainties, there areimportant factors that could cause actual results to differ materially fromthose expressed implied by the forward-looking statements including, butwithout limitation, economic conditions in general and in the healthcaremarket, the demand for and market for our products in domestic andinternational markets, our current dependence on the CALM product suite, thechallenges associated with developing new products and obtaining regulatoryapprovals if necessary, research and development activities, the uncertaintyof acceptance of our products by the medical community, the lengthy salescycle for our products, third party reimbursement, competition in our markets,including the potential introduction of competitive products by others, ourdependence on our distributors, physician training, enforceability and thecosts of enforcement of our patents, potential infringements of our patentsand the other factors set forth from time to time in the Company's filingswith the United States Securities and Exchange Commission and with theCanadian Securities Commissions. The Company has no intention of or obligationto update or revise any forward-looking statements, whether as a result of newinformation, future events or otherwise.



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
SheKnows Acquires PregnancyandBaby - Online Commun...
Triple-S Management Corporation Appoints New Non-E...